| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285962 | Parkinsonism & Related Disorders | 2016 | 6 Pages |
Abstract
The CCI is probably the better scale for measuring co-morbidity burden in PD. There were no differences between PD and controls. Co-morbidity burden at diagnosis was associated with mortality in the early part of the disease course, but not later.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Angus D. Macleod, Hannah Goddard, Carl E. Counsell,